Menu
Subscribe to our Email Alerts
Home
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Pipeline
Cancer Program
Fibrosis Program
Clinical Trial
Investor Information
Welcome
Investor Fact Sheet
Investor Presentations
Media
Top 20 Shareholders
Shareholder Services
Investor FAQs
US Shareholders
Announcements and Reports
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
Contact Us
Contact Us
Email Alerts
Announcements and Reports
Home
>
Announcements and Reports
>
ASX Announcements
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
ASX Announcements
Filter by Year:
2023
2022
2021
2020
2019
2018
28-Apr-2020
App 4C - Quarterly Cash Flow Report - March 2020 Qtr
7-Apr-2020
Shares to be Released from Voluntary Escrow
25-Mar-2020
FDA Awards Orphan Drug Designation for Pancreatic Cancer
13-Feb-2020
Professor Paul Timpson Joins Amplia's SAB
12-Feb-2020
Initial Director's Interest Notice - John Lambert
7-Feb-2020
Final Director's Interest Notice - Behrenbruch
7-Feb-2020
Final Director's Interest Notice - Wilkinson
7-Feb-2020
Final Director's Interest Notice - Cooke
6-Feb-2020
Dr. John Lambert appointed as Managing Director
6-Feb-2020
Board Restructuring
Previous
1
2
3
4
5
6
7
Next
